According to Gram Research analysis, high-fat diets cause people with gut inflammation to lose excessive oxalate through their urine, increasing kidney stone risk. A 2026 study in mice with inflammatory bowel disease found that high-fat diets prevent proper fat absorption, which reduces calcium available to bind oxalate in the intestines. This allows more oxalate to be absorbed into the bloodstream and filtered into urine, where it crystallizes into kidney stones. The study also revealed that intestinal leakiness and changes in gut bacteria compound this problem.
Researchers studied why people with inflammatory bowel disease develop high levels of oxalate (a substance that forms kidney stones) in their urine. Using mice with gut inflammation, they found that high-fat diets prevent the body from absorbing fat properly, which then reduces calcium available to bind with oxalate. This combination of poor fat absorption, leaky intestines, and changes in gut bacteria creates the perfect conditions for kidney stone formation. The study reveals that managing fat intake and gut health might help prevent this painful complication in people with inflammatory bowel disease.
Key Statistics
A 2026 research article in Gut Microbes found that mice with gut inflammation fed high-fat diets had significantly higher urinary and plasma oxalate levels compared to control mice without inflammation, demonstrating a direct link between fat malabsorption and kidney stone risk.
According to the 2026 study, SAMP1 mice with gut inflammation showed reduced intestinal barrier proteins (ZO1 and occludin) and increased intestinal permeability, with sucralose appearing in urine at significantly higher levels than in control mice, confirming leaky gut as a contributing factor.
The research revealed that SAMP1 mice developed progressive kidney injury with interstitial inflammation when fed high-fat diets supplemented with oxalate, suggesting that chronic oxalate overload damages kidney tissue over time.
The 2026 analysis found that gut bacteria in inflamed mice were enriched in Lactobacilli and Bacteroides species with active genes for lipid synthesis and glyoxylate metabolism, linking microbiome changes to increased oxalate production.
The Quick Take
- What they studied: How high-fat diets cause the body to lose too much oxalate through urine in mice with gut inflammation, leading to kidney stone risk
- Who participated: Two types of laboratory mice: SAMP1 mice (which develop gut inflammation naturally) and AKR control mice (which don’t get inflamed). Mice were fed diets with different fat levels for 6 weeks
- Key finding: SAMP1 mice on high-fat diets had significantly higher oxalate levels in their urine and blood compared to control mice, along with signs of poor fat absorption and leaky intestines
- What it means for you: People with inflammatory bowel disease who eat high-fat diets may be at greater risk for kidney stones. Reducing fat intake and managing gut inflammation could potentially lower this risk, though human studies are needed to confirm
The Research Details
Researchers used two groups of mice: one type that naturally develops gut inflammation (SAMP1) and one that doesn’t (AKR controls). They fed each group three different diets—low fat (10%), medium fat (45%), or high fat (60%)—all containing 1% oxalate, for 6 weeks. They then measured oxalate levels in blood and urine, examined stool samples for undigested fat, tested how “leaky” the intestines were, and analyzed the gut bacteria using advanced genetic techniques.
The researchers also looked at kidney tissue under a microscope to see if damage occurred, measured specific proteins in the intestines that control permeability, and studied which bacterial genes were active in the mice’s guts. This multi-layered approach allowed them to understand not just what happened, but why it happened.
This research approach is important because it shows that kidney stone risk in gut disease isn’t caused by just one problem—it’s a combination of factors working together. By studying multiple systems (fat absorption, intestinal barrier, bacteria, and kidney function) at the same time, the researchers could identify the root cause rather than just treating symptoms. This helps doctors understand what to target with treatment.
This is a controlled laboratory study using genetically similar mice, which allows researchers to isolate specific causes. The study measured multiple related outcomes (fat absorption, intestinal permeability, bacterial composition, and kidney damage) rather than relying on a single measurement, making the findings more reliable. However, because this is animal research, results may not directly apply to humans without further testing. The study was published in a peer-reviewed journal, meaning other experts reviewed the methods and findings.
What the Results Show
When SAMP1 mice (with gut inflammation) ate high-fat diets, they had significantly higher levels of oxalate in both their urine and blood compared to control mice without inflammation. The researchers found undigested fat in the stool samples of SAMP1 mice, showing their bodies weren’t absorbing fat properly. This poor fat absorption is the key problem: when fat isn’t absorbed, it uses up calcium in the intestines, leaving less calcium available to bind with oxalate. Without calcium to bind to it, oxalate gets absorbed into the bloodstream and filtered into the urine, where it can form kidney stones.
The intestines of SAMP1 mice also showed signs of being “leaky”—the protective barrier that normally keeps harmful substances out was damaged. Specific proteins that seal the intestinal lining (called ZO1 and occludin) were reduced in SAMP1 mice. When researchers gave these mice a special sugar (sucralose) that shouldn’t normally pass through the intestine, they found high levels in the urine, confirming the intestines were leaking.
The gut bacteria in SAMP1 mice were different from control mice, with more Lactobacilli and Bacteroides bacteria. These bacteria had active genes related to processing fats and making a substance called glyoxylate, which can be converted to oxalate. Additionally, a protein in the intestine that normally helps remove oxalate (called SLC26A6) was significantly reduced in SAMP1 mice, meaning less oxalate could be actively removed from the body.
The SAMP1 mice developed progressive kidney damage with inflammation in the kidney tissue, suggesting that high oxalate levels actually harm the kidneys over time. The combination of fat malabsorption, intestinal leakiness, and bacterial changes created a perfect storm for kidney stone formation. The study showed that these problems were interconnected—fixing one problem alone wouldn’t solve the issue; all three factors needed to be addressed.
Previous research showed that people with inflammatory bowel disease have higher kidney stone risk, but the exact mechanism wasn’t clear. This study confirms what researchers suspected: that fat malabsorption is the central problem, not just inflammation itself. The finding that gut bacteria changes accompany this process is newer and suggests that probiotics or dietary changes targeting the microbiome might help. The study also confirms that intestinal permeability (leaky gut) plays a role in oxalate absorption, supporting earlier research in this area.
This study was conducted in mice, not humans, so results may not directly apply to people with inflammatory bowel disease. The mice were fed very high oxalate levels (1%) compared to typical human diets, which may exaggerate the effect. The study doesn’t show whether treating fat malabsorption or changing the microbiome would actually reduce kidney stone risk. Additionally, the study doesn’t specify exactly how many mice were used in each group, making it harder to assess statistical power. Finally, this is a snapshot of what happens over 6 weeks; longer-term effects remain unknown.
The Bottom Line
People with inflammatory bowel disease should consider moderating fat intake, especially during flare-ups when fat absorption is poor (moderate confidence based on animal research). Maintaining good gut health through anti-inflammatory diet and possibly probiotics may help, though human evidence is limited. Anyone with inflammatory bowel disease should work with their doctor to monitor kidney function and oxalate levels, especially if they have a family history of kidney stones (high confidence recommendation based on general medical practice). Do not self-treat or change diet without medical guidance.
People with inflammatory bowel disease (Crohn’s disease or ulcerative colitis), especially those with a history of kidney stones or high oxalate levels. People with other conditions causing fat malabsorption should also pay attention. This research is less immediately relevant to people without gut inflammation, though it may inform future prevention strategies. Healthcare providers treating IBD patients should consider this research when counseling about diet and kidney stone prevention.
Changes in oxalate levels might occur within weeks of dietary changes, but kidney damage develops over months to years. Improvements in gut bacteria composition typically take 2-4 weeks of dietary changes. Kidney function improvements would take longer to measure and would require medical monitoring.
Frequently Asked Questions
Does a high-fat diet cause kidney stones in people with Crohn’s disease or ulcerative colitis?
Research suggests high-fat diets may increase kidney stone risk in people with inflammatory bowel disease by reducing fat absorption and calcium availability to bind oxalate. A 2026 animal study showed this mechanism clearly, but human studies are needed to confirm. Consult your doctor about appropriate fat intake for your condition.
Can changing my diet prevent kidney stones if I have inflammatory bowel disease?
Potentially yes. Reducing fat intake and maintaining adequate hydration may help lower oxalate levels in urine. A 2026 study showed that fat malabsorption drives oxalate loss in gut inflammation. However, individual responses vary, and you should work with your healthcare provider to develop a personalized prevention strategy.
What is the connection between gut bacteria and kidney stones?
Gut bacteria in people with inflammation produce different metabolic byproducts that increase oxalate production. A 2026 study found enriched Lactobacilli and Bacteroides with active genes for glyoxylate metabolism in inflamed mice. This suggests that probiotics or dietary changes targeting the microbiome might reduce kidney stone risk, though human evidence is limited.
How does a leaky gut contribute to kidney stone formation?
A leaky gut allows more oxalate to pass through the intestinal barrier into the bloodstream, where it’s filtered into urine and can form stones. A 2026 study showed that mice with gut inflammation had reduced intestinal barrier proteins and increased permeability, allowing more oxalate absorption compared to healthy mice.
Should I avoid all fats if I have inflammatory bowel disease and kidney stone risk?
No, you need some fat for nutrition. Instead, work with your doctor to find an appropriate fat level for your individual condition. A 2026 study showed that excessive fat (especially when poorly absorbed) increases kidney stone risk, but moderate, well-absorbed fat is necessary for health. Personalized guidance is essential.
Want to Apply This Research?
- Track daily fat intake (grams) and urine color/frequency as a proxy for hydration and oxalate concentration. Users with IBD should log these alongside bowel movement consistency to identify patterns between fat intake, gut symptoms, and kidney stone risk factors
- Set a daily fat intake target (work with doctor to determine appropriate level), log meals with fat content, and receive alerts when approaching the target. Users can also track water intake to dilute urine and reduce stone formation risk
- Monthly review of fat intake patterns correlated with symptom severity; quarterly check-ins with healthcare provider for kidney function tests and urinalysis; long-term tracking of kidney stone episodes to identify personal triggers
This article summarizes animal research and should not be considered medical advice. Findings from mouse studies may not directly apply to humans. People with inflammatory bowel disease who are concerned about kidney stone risk should consult with their gastroenterologist or nephrologist before making dietary changes. Do not modify your diet or supplement regimen based solely on this research without professional medical guidance. If you experience symptoms of kidney stones (severe back or side pain, painful urination, blood in urine), seek immediate medical attention. This research is preliminary and requires human clinical trials before clinical recommendations can be made.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.